AAAAAA
Results: 1-25/44
Authors:
Barth, TFE
Bentz, M
Dohner, H
Moller, P
Citation: Tfe. Barth et al., Molecular aspects of B-cell lymphomas of the gastrointestinal tract, CLIN LYMPHO, 2(1), 2001, pp. 57-64
Authors:
Barth, TFE
Bentz, M
Leithauser, F
Stilgenbauer, S
Siebert, R
Schlotter, M
Schlenk, RF
Dohner, H
Moller, P
Citation: Tfe. Barth et al., Molecular-cytogenetic comparison of mucosa-associated marginal zone B-celllymphoma and large B-cell lymphoma arising in the gastro-intestinal tract, GENE CHROM, 31(4), 2001, pp. 316-325
Authors:
Bentz, M
Barth, TFE
Bruderlein, S
Bock, D
Schwerer, MJ
Baudis, M
Joos, S
Viardot, A
Feller, AC
Muller-Hermelink, HK
Lichter, P
Dohner, H
Moller, P
Citation: M. Bentz et al., Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): Comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line, GENE CHROM, 30(4), 2001, pp. 393-401
Authors:
Wolf, S
Mertens, D
Schaffner, C
Korz, C
Dohner, H
Stilgenbauer, S
Lichter, P
Citation: S. Wolf et al., B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions, HUM MOL GEN, 10(12), 2001, pp. 1275-1285
Authors:
Dohner, H
Citation: H. Dohner, Information and counselling - A contribution to health promotion and-health care, Z GERON GER, 34(1), 2001, pp. 48-55
Authors:
Wessendorf, S
Lichter, P
Schwanen, C
Fritz, B
Baudis, M
Walenta, K
Kloess, M
Dohner, H
Bentz, M
Citation: S. Wessendorf et al., Potential of chromosomal and matrix-based comparative genomic hybridization for molecular diagnostics in lymphomas, ANN HEMATOL, 80, 2001, pp. B35-B37
Authors:
Marcucci, G
Caligiuri, MA
Dohner, H
Archer, KJ
Schlenk, RF
Dohner, K
Maghraby, EA
Bloomfield, CD
Citation: G. Marcucci et al., Quantification of CBF beta/MYH11 fusion transcript by Real Time RT-PCR in patients with INV(16) acute myeloid leukemia, LEUKEMIA, 15(7), 2001, pp. 1072-1080
Authors:
Reske, SN
Bunjes, D
Buchmann, I
Seitz, U
Glatting, G
Neumaier, B
Kotzerke, J
Buck, A
Martin, H
Dohner, H
Bergmann, L
Citation: Sn. Reske et al., Targeted bone marrow irradiation in the conditioning of high-risk leukaemia prior to stem cell transplantation, EUR J NUCL, 28(7), 2001, pp. 807-815
Authors:
Frohling, S
Nakabayashi, K
Scherer, SW
Dohner, H
Dohner, K
Citation: S. Frohling et al., Mutation analysis of the origin recognition complex subunit 5 (ORC5L) genein adult patients with myeloid leukemias exhibiting deletions of chromosome band 7q22, HUM GENET, 108(4), 2001, pp. 304-309
Authors:
Ringhoffer, M
Dohner, K
Scheil, S
Wilts, H
Mertens, T
Grimminger, W
Dohner, H
Bunjes, D
Citation: M. Ringhoffer et al., Fatal outcome in a patient developing Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD) without measurable disease, BONE MAR TR, 28(6), 2001, pp. 615-618
Authors:
Dohner, H
Stilgenbauer, S
Lichter, P
Citation: H. Dohner et al., Chromosomal abnormalities in chronic lymphocytic leukemia. Reply, N ENG J MED, 344(16), 2001, pp. 1254-1254
Authors:
Seute, A
Sinn, HP
Schlenk, RF
Emig, R
Wallwiener, D
Grischke, EM
Hohaus, S
Dohner, H
Haas, R
Bentz, M
Citation: A. Seute et al., Clinical relevance of genomic aberrations in homogeneously treated high-risk stage II/III breast cancer patients, INT J CANC, 93(1), 2001, pp. 80-84
Authors:
Stratowa, C
Loffler, G
Lichter, P
Stilgenbauer, S
Haberl, P
Schweifer, N
Dohner, H
Wilgenbus, KK
Citation: C. Stratowa et al., cDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking, INT J CANC, 91(4), 2001, pp. 474-480
Authors:
Voss, T
Ahorn, H
Haberl, P
Dohner, H
Wilgenbus, E
Citation: T. Voss et al., Correlation of clinical data with proteomics profiles in 24 patients with B-cell chronic lymphocytic leukemia, INT J CANC, 91(2), 2001, pp. 180-186
Authors:
Hallek, M
Schmitt, B
Wilhelm, M
Busch, R
Krober, A
Fostitsch, HP
Sezer, O
Herold, M
Knauf, W
Wendtner, CM
Kuse, R
Freund, M
Franke, A
Schriever, F
Nerl, C
Dohner, H
Thiel, E
Hiddemann, W
Brittinger, G
Emmerich, B
Citation: M. Hallek et al., Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia, (CLL): results of a phase II study of the German CLL Study Group, BR J HAEM, 114(2), 2001, pp. 342-348
Authors:
Bunjes, D
Buchmann, I
Duncker, C
Seitz, U
Kotzerke, J
Wiesneth, M
Dohr, D
Stefanic, M
Buck, A
Harsdorf, SV
Glatting, G
Grimminger, W
Karakas, T
Munzert, G
Dohner, H
Bergmann, L
Reske, SN
Citation: D. Bunjes et al., Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study, BLOOD, 98(3), 2001, pp. 565-572
Authors:
Dohner, K
Hehmann, U
Brown, J
Hetzel, C",Stewart,"Lowther, G
Scholl, C
Frohling, S
Cuneo, A
Tsui, LC
Lichter, P
Scherer, SW
Dohner, H
Citation: K. Dohner et al., Molecular cytogenetic characterization of a critical region in bands 7q35-q36 commonly deleted in malignant myeloid disorders, HEMAT BLOOD, 40, 2001, pp. 15-19
Authors:
Schlenk, RF
Frohling, S
Del Valle, F
Hartmann, F
Glasmacher, A
Fischer, JT
Grimminger, W
Weber, C
Weber, W
Gunzer, U
Gotze, K
Waterhouse, C
Benner, A
Dohner, K
Haas, R
Ho, AD
Dohner, H
Citation: Rf. Schlenk et al., Stratification of postremission therapy in patients with acute myeloid leukemia <= 60 years according to the karyotype: Results of the German multicenter treatment trials AML HD93 and AML HD98-A, HEMAT BLOOD, 40, 2001, pp. 470-476
Authors:
Frohling, S
Schlenk, RF
Del Valle, F
Hartmann, F
Glasmacher, A
Fischer, JT
Grimminger, W
Weber, C
Weber, W
Gunzer, U
Gotze, K
Dohner, K
Haas, R
Ho, AD
Dohner, H
Citation: S. Frohling et al., Chemotherapy and all-trans retinoic acid in patients > 60 years with acutemyeloid leukemia: First results of the multicenter treatment trial AML HD98-B, HEMAT BLOOD, 40, 2001, pp. 604-608
Authors:
Barth, TFE
Benner, A
Bentz, M
Dohner, H
Moller, P
Lichter, P
Citation: Tfe. Barth et al., Risk of false positive results in comparative genomic hybridization, GENE CHROM, 28(3), 2000, pp. 353-357
Authors:
Bentz, M
Plesch, A
Bullinger, L
Stilgenbauer, S
Ott, G
Muller-Hermelink, HK
Baudis, M
Barth, TFE
Moller, P
Lichter, P
Dohner, H
Citation: M. Bentz et al., t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia, GENE CHROM, 27(3), 2000, pp. 285-294
Authors:
Gahn, B
Brittinger, G
Dolken, G
Dohner, H
Emmerich, B
Franke, A
Freund, M
Huber, C
Kuse, R
Scholten, T
Hiddemann, W
Citation: B. Gahn et al., Multicenter phase II study of oral idarubicin in treated and untreated patients with B-chronic lymphocytic leukemia, LEUK LYMPH, 37(1-2), 2000, pp. 169-173
Authors:
Stilgenbauer, S
Schaffner, C
Winkler, D
Ott, G
Leupolt, E
Bentz, M
Moller, P
Muller-Hermelink, HK
James, MR
Lichter, P
Dohner, H
Citation: S. Stilgenbauer et al., The ATM gene in the pathogenesis of mantle-cell lymphoma, ANN ONCOL, 11, 2000, pp. 127-130
Authors:
Bullinger, L
Leupolt, E
Schaffner, C
Mertens, D
Bentz, M
Lichter, P
Dohner, H
Stilgenbauer, S
Citation: L. Bullinger et al., BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma, LEUKEMIA, 14(8), 2000, pp. 1490-1492
Authors:
Dohner, K
Schlenk, RF
van der Reijden, BA
Dohner, H
Citation: K. Dohner et al., Deletion of the multidrug resistance-associated protein (MRP1) gene in acute myeloid leukemia with inversion of chromosome 16 has no prognostic impact, LEUKEMIA, 14(6), 2000, pp. 1154-1154